Atai Beckley
ATAI
Performance
About Atai Beckley
AtaiBeckley is a biotechnology company focused on developing mental health treatments with patient-centric, evidence-based approaches. The company aims to transform outcomes by delivering rapid-acting and convenient therapies for mental health conditions, pursuing a broad pipeline and therapeutic areas. It emphasizes clinical research, collaboration, and leadership in drug development to address global mental health needs and improve access to effective care.
Recent News
Psychedelic Stocks Jump as High as 40% After Trump Supports Using Drugs Like LSD for Mental Health
FDA Greenlights First Ibogaine Derivative Trial and Fast‑tracks Three Psychedelics
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
Trump's Executive Order Fast‑Tracks Psychedelic Therapy Review, Boosting Compass Pathways
Recent Deals
No recent deals for this company.